Transgenic mice expressing Tax through HTLV-1 LTR were found to develop neurofibrosarcomas [221], mesenchymal tumors [222] or skeletal bone abnormalities [223], but not leukemias or lymphomas. Here, CNTN2 is linked to leukemia.